Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results
Go back to Krystal Biotech Announces Second Quarter 2026 Financial and Operating Results| (NASDAQ: KRYS) | Delayed: 358.94 -0.82 (0.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $359.76 | 52 Week High | $ | |||
| Open | $357.61 | 52 Week Low | $ | |||
| Day High | $362.48 | P/E | N/A | |||
| Day Low | $356.44 | EPS | $ | |||
| Volume | 13,969 | |||||

